weight loss

Medicare coverage of weight loss drugs would cost $35B: CBO
The Hill
Wed, 10/9/24 - 08:56 pm
Medicare
obesity
weight loss
CBO
Weight loss gold rush: Developers vie for next blockbuster treatment
Pharmaphorum
Tue, 10/8/24 - 09:45 am
R&D
obesity
weight loss
Novo Nordisk
Eli Lilly
Roche
Boehringer Ingelheim
Weight Loss From GLP-1 Drugs Not As Robust In Real-World Settings
Forbes
Wed, 10/2/24 - 11:20 am
weight loss
obesity
GLP-1 agonist
Ozempic
Wegovy
Novo Nordisk
Zepbound
Mounjaro
Eli Lilly
Inside the GLP-1 'price war'
Beckers Hospital Review
Tue, 09/24/24 - 11:52 am
GLP-1 agonists
obesity
weight loss
Eli Lilly
Novo Nordisk
Ozempic
Wegovy
Zepbound
Mounjaro
drug pricing
Novo obesity prospect linked to ‘mild to moderate neuropsychiatric side effects’ in phase 2
Fierce Biotech
Fri, 09/20/24 - 11:30 am
Novo Nordisk
obesity
weight loss
clinical trials
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
CNBC
Thu, 09/19/24 - 11:13 am
Novartis
Pharma CEOs
weight loss
obesity
Vas Narasimhan
Weight-loss market to see 16 new drugs by 2029, report estimates
Reuters
Tue, 09/10/24 - 04:29 pm
weight loss
obesity
Amgen
Pfizer
Roche
Novo Nordisk
Eli Lilly
Boehinger Ingelheim
Structure Therapeutics
Viking Therapeutics
Zealand Pharma
Altimmune
Lilly demands doctors stop selling copycat weight-loss drugs
Reuters
Thu, 08/15/24 - 11:50 am
Eli Lilly
drug counterfeiting
Zepbound
weight loss
Doctors struggle to get Wegovy for older Americans with heart disease
Reuters
Thu, 08/15/24 - 11:41 am
Novo Nordisk
Medicare
Wegovy
physicians
weight loss
Access is unequal to weight-loss drugs Ozempic and Wegovy: study
Axios
Mon, 08/5/24 - 11:08 am
Novo Nordisk
Ozempic
Wegovy
patient access
insurers
Medicaid
Medicare
weight loss
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
Motley Fool
Sun, 08/4/24 - 06:30 pm
AstraZeneca
Pharma CEOs
weight loss
obesity
Pascal Soriot
Lilly CEO says weight-loss drug shortage to end 'very soon', Bloomberg News reports
Reuters
Thu, 08/1/24 - 11:13 pm
Eli Lilly
weight loss
Zepbound
drug shortages
Novo Nordisk launches weight-loss drug Wegovy in Australia
Reuters
Thu, 08/1/24 - 11:11 pm
Novo Nordisk
Wegovy
Australia
weight loss
GLP-1 drugs are driving up healthcare costs
Medical Marketing and Media
Fri, 07/26/24 - 11:03 am
obesity
weight loss
GLP-1 agonist
healthcare costs
Eli Lily
Novo Nordisk
Wegovy
Zepbound
5 startups looking to compete in the obesity space
BioSpace
Mon, 07/22/24 - 12:03 pm
startups
obesity
weight loss
Metsera
35Pharma
ProFound Therapeutics
Metaphore
EraCal Therapeutics
Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.
Motley Fool
Sun, 07/21/24 - 11:02 pm
Pfizer
obesity
weight loss
Will Eli Lilly overtake Novo Nordisk in weight-loss drug race?  
BioSpace
Tue, 07/16/24 - 12:11 pm
Eli Lilly
Novo Nordisk
Wegovy
Zepbound
weight loss
Pfizer moves forward with once-daily version of weight loss pill after setbacks
CNBC
Thu, 07/11/24 - 11:57 am
Pfizer
weight loss
danuglipron
Most patients stop using Wegovy, Ozempic for weight loss within two years
Reuters
Wed, 07/10/24 - 11:04 am
Novo Nordisk
Wegovy
Ozempic
weight loss
patients
Ozempic's popularity leads to shortages for people with Type 2 diabetes
NPR
Wed, 07/10/24 - 11:01 am
Novo Nordisk
diabetes
Ozempic
weight loss
drug shortages

Pages